Wednesday - October 28, 2026
Ropes and Gray: Teva Pharmaceuticals Completes Acquisition of Novel Neuroscience Assets From BioXcel Therapeutics
October 28, 2026
BOSTON, Massachusetts, Oct. 28 -- Ropes and Gray, a law firm, issued the following news:

* * *

Teva Pharmaceuticals Completes Acquisition of Novel Neuroscience Assets from BioXcel Therapeutics

October 27, 2026

Ropes & Gray represented Teva Pharmaceuticals in its acquisition of certain neuroscience assets from BioXcel Therapeutics. The completed transaction was announced on October 27.

Teva acquired the assets out of BioXcel . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products